For instance, the combination of PD-1/PD-L1 blockade with agents that enhance regulatory T-cell function or suppress pro-inflammatory cytokines may potentially exert a synergistic effect on immune response modulation and contribute to the promotion of plaque stability in atherosclerosis [32]. This evidence concerns the gene PDCD1 and atherosclerosis.